<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-02-09">February 9, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Zofia</forename><surname>Wotschofsky</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Linda</forename><surname>Gummlich</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of General, Visceral, Vascular and Thoracic Surgery</orgName>
								<orgName type="department" key="dep2">Division of Molecular Biology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julia</forename><surname>Liep</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Stephan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ergin</forename><surname>Kilic</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Klaus</forename><surname>Jung</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Jean-Noel</forename><surname>Billaud</surname></persName>
							<email>jean-noel.billaud@qiagen.com</email>
							<affiliation key="aff4">
								<orgName type="laboratory">QIAGEN</orgName>
								<address>
									<addrLine>1700 Seaport Blvd</addrLine>
									<settlement>Redwood City</settlement>
									<region>California</region>
									<country>United States of America</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hellmuth-Alexander</forename><surname>Meyer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<country key="CN">CHINA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Foundation Urologic Research</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-02-09">February 9, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">6801FE1C7591127DA40F809C601471D9</idno>
					<idno type="DOI">10.1371/journal.pone.0148746</idno>
					<note type="submission">Received: August 23, 2015 Accepted: January 11, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:51+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>MicroRNAs (miRNAs) regulate gene expression by interfering translation or stability of target transcripts.</s><s>This interplay between miRNA and their mRNA has been proposed as an important process in cancer development and progression.</s><s>We have investigated molecular networks impacted by predicted mRNA targets of differentially expressed miRNAs in patients with clear cell renal cell carcinoma (ccRCC) diagnosed with or without metastasis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and Methods</head><p><s>miRNA and mRNA microarray expression profiles derived from primary ccRCC from patients with (16 samples) or without diagnosed metastasis (22 samples) were used to identify anti-correlated miRNA-mRNA interaction in ccRCC.</s><s>For this purpose, Ingenuity pathway analysis microRNA Target Filter, which enables prioritization of experimentally validated and predicted mRNA targets was used.</s><s>By applying an expression pairing tool, the analysis was focused on targets exhibiting altered expression in our analysis, finding miRNAs and their target genes with opposite or same expression.</s><s>The resulting identified interactions were revalidated by RT-qPCR in another cohort of ccRCC patients.</s><s>A selection of the predicted miRNA-mRNA interactions was tested by functional analyses using miRNA knockdown and overexpression experiments in renal cancer cell lines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Among the significantly differentially expressed miRNAs, we have identified three miRNAs (miR-146a-5p, miR-128a-3p, and miR-17-5p) that were upregulated in primary tumors from patients without metastasis and downregulated in primary tumors from patients with PLOS ONE |</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Funding: This work was supported by fellowships from the Foundation Urologic Research, Berlin, Germany for Julia Liep (JL) and Linda Gummlich (LG) as part of their doctoral thesis.</s><s>The sponsor had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.</s><s>QIAGEN provided support</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Renal cell carcinoma (RCC) is the most common type of kidney tumor in adults.</s><s>In United States, 61560 new cases of RCC are expected in 2015 and almost 30% of these patients will eventually succumb to their disease in the next 5 years <ref type="bibr" target="#b0">[1]</ref>.</s><s>In general, primary RCC shows no typical early clinical symptoms, therefore the tumor is most often first discovered by a routine ultrasonic investigations.</s><s>At this time point, approximately 20% of the patients already show distant metastases and another 30% of the patients will develop metastases after radical nephrectomy <ref type="bibr" target="#b1">[2]</ref>.</s><s>There are three main different morphotypes of RCC <ref type="bibr" target="#b2">[3]</ref>.</s><s>Clear cell RCC (ccRCC) accounts for approximately 80-90% of all RCCs, while 6-15% and 2-5%, respectively are papillary RCCs and chromophobe RCCs.</s><s>Both this high frequency of ccRCC but also the significantly worse clinical outcome for patients with ccRCC after nephrectomy compared with patients suffering from papillary or chromophobe RCC determine the clinical significance of ccRCC <ref type="bibr" target="#b2">[3]</ref>.</s><s>The standard treatment of localized RCC is the radical tumor nephrectomy, whereas in recent years a nephron sparing surgery has emerged as a safe alternative for small primary tumors <ref type="bibr" target="#b3">[4]</ref>.</s><s>In case of metastatic RCC, the mainly infested organs are lungs, bones, liver and brain, which cause a high morbidity and a poor prognosis.</s><s>At the moment, there is no general effective curative treatment for metastatic RCC.</s><s>Nevertheless, considerable progress has been made due to the introduction of individualized therapies by using tyrosine kinase inhibitors and angiogenesis inhibitors <ref type="bibr" target="#b4">[5]</ref>.</s><s>In the case of transition from a primary RCC without metastases into a tumor generating distant metastasis, there is a clear need for novel prognostic biomarkers to ensure adequate risk stratification and to help with the choice of therapy options <ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>MicroRNAs (miRNAs) play a key role in gene regulation, they are now being explored to identify potential disease biomarkers and new targets <ref type="bibr" target="#b6">[7]</ref>.</s><s>Several miRNA and mRNA expression studies have been conducted to characterize the molecular mechanisms of ccRCC development <ref type="bibr" target="#b6">[7]</ref> and a genome atlas of this tumor was recently established <ref type="bibr" target="#b7">[8]</ref>.</s><s>To get a deeper insight into the process of tumor transition from primary ccRCC into a tumor which is capable to generating distant metastases an integrated analysis of both miRNA and mRNA expression data is advisable <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s>The data from our previous miRNA expression studies of ccRCC tissue samples showed that progression from non-metastatic to metastatic tumor was not always reflected by a continuous process of molecular changes in a straight line <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s><s>We observed different expression shifts in this transition process, surely a consequence of the multiple interactions between the various molecular cellular components.</s><s>Thus, we believe that the study of molecular alterations in the primary tumor could better characterize this transition process from nonmetastatic to the metastatic tumor than examination of metastatic lesions.</s></p><p><s>in the form of salaries (JNB) for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s><s>The specific roles of these authors are articulated in the author contributions section.</s></p><p><s>Unfortunately, searching miRNA databases for predicted and observed mRNAs yields thousands of potential targets <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b14">15]</ref>, and this is a significant challenge for identifying and classifying the truly relevant targets.</s><s>Moreover, the inherent variability in experimental samples, technology platforms, and analysis methods makes finding targets that translate well to biomarkers that much more difficult.</s><s>Therefore, integrated tools were needed to analysis miRNA and mRNA data as well as involved biological relationships in one process.</s><s>For this purpose, Ingenuity Pathway Analysis (IPA 1 ) was used (QIAGEN Redwood City, CA, www.qiagen.</s><s>com/ingenuity).</s><s>The IPA 1 's microRNA Target Filter enables to go directly from preprocessed miRNA expression data to zeroing in on the most promising mRNA targets by using known biological evidence around molecular interactions and disease mechanisms whether or not we have mRNA measurements from the same sample.</s></p><p><s>Thus, the aim of our study was to use the IPA 1 's MicroRNA Target Filter platform to explore new interactions between miRNAs and mRNAs in ccRCC for detecting novel biomarkers or targets.</s><s>The usefulness of this tool in this promising research concept could be demonstrated by the example of miR-146a-5p and its potential targets chemokine (C-X-C motif) ligand 8/interleukin 8 (CXCL8; alias IL8), ubiquitin-like with PHD and ring finger domains 1 (UHRF1), breast cancer 1, early onset (BRCA1), minichromosome maintenance complex component 10 (MCM10), and cyclin-dependent kinase inhibitor 3 (CDKN3).</s><s>The experimental validation of this approach was shown by means of the modulation of the expression of CXCL8 and UHRF1 on mRNA and protein level in cell culture experiments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and tissue samples</head><p><s>The ccRCC samples were obtained during partial or radical nephrectomy at the University Hospital Charité in Berlin between 2004 and 2008.</s><s>The study was approved by the Ethic Committee of the University Hospital Charité (EA1/153/07 and EA1/153/12: "microRNAs as diagnostic and prognostic signatures in urological tumors").</s><s>The study was conducted in compliance with the declaration of Helsinki and written informed consent has been obtained.</s><s>The staging and grading of the tumor samples were classified according to the 2002 TNM classification and the Fuhrman grading system <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>All tissue samples were frozen in liquid nitrogen directly after surgical resection and stored at -80°C until RNA extraction.</s></p><p><s>miRNA microarray expression profiles were generated from a selection of 24 matched malignant and non-malignant kidney tissue samples from a collective of ccRCC patients described previously <ref type="bibr" target="#b12">[13]</ref>.</s><s>In detail, samples from 8 patients without diagnosed metastasis (ccRCC-M0; 5 male and 3 female patients; median age 67, range 39-73 years; tumor staging: 1x pT1, 1x pT2, and 6x pT3; grading: 6x G2 and 2x G3) and from 4 patients with diagnosed metastasis (ccRCC-M1; 2 male and 2 female patients; median age 64.5, range 57-74 years; tumor staging: 4x pT3; grading: 1x G1 and 3x G2) were analyzed.</s></p><p><s>mRNA microarray expression analysis was performed by using two different collectives of RCC patients.</s><s>The first set contained 28 matched malignant and non-malignant kidney tissue samples from 14 ccRCC-M0 patients (11 male and 3 female patients; median age 66, range 45-78 years; tumor staging: 10x pT1, 1x pT2, and 3x pT3; grading: 1x G1 and 13x G2).</s><s>The second set consisted of 26 matched malignant and non-malignant kidney tissue samples from 13 ccRCC-M1 patients (8 male and 5 female patients; median age 62, range 40-75 years; tumor staging: 2x pT1, 10x pT3, and 1x pT4; grading: 3x G2; 8x G4, and 2x G4).</s></p><p><s>For the quantitative real-time reverse-transcription PCR (RT-qPCR) analysis, another set of patients was used, containing 10 non-malignant kidney tissue samples of ccRCC patients (median age 58, range 41-75), 10 tissue samples of primary ccRCC from ccRCC-M0 patients (9 male and 1 female patients; median age 67, range 39-73 years; tumor staging: 4x pT1a, 3x pT1b, 1x pT2, and 2x pT3a; grading: 2x G1 and 8x G2) and 10 tissue samples of primary ccRCC from ccRCC-M1 patients (6 male and 4 female patients; median age 60.5, range 40-74 years; tumor staging: 3x pT3a, 4x pT3b, 1x pT3c, and 2x pT4; grading: 4x G2, 5x G3, and 1x G4).</s></p><p><s>miRNA microarray expression analysis miRNA expression analysis was performed as described before with one-color hybridizations on human catalog 8-plex 15 K microRNA microarrays (AMADID 016436; Agilent Technologies, Santa Clara, CA, USA) encoding probes for 470 human and 64 human viral miRNAs from the Sanger database v9.1 <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s>After scanning, features were extracted with the image analysis tool version A.9.5.3 using default protocols and settings (Agilent Technologies).</s><s>The raw scan data were interpreted using Genespring GX11 Software (Agilent Technologies) with default input parameters (threshold raw signal to 1.0, percent shift to 90th percentile as normalization algorithm and no baseline transformation).</s><s>The corresponding expression data were archived under the GEO Accession No. GSE37989.</s></p><p><s>mRNA microarray expression analysis mRNA expression analysis was performed by one-color hybridizations on Human Genome U133 Plus 2.0 Arrays (Affymetrix, Santa Clara, CA, USA).</s><s>After hybridization, microarrays were washed, scanned, and processed according to the supplier's protocol (Affymetrix).</s><s>The raw data were normalized using Genespring GX11 Software (Agilent Technologies) with default parameters (MAS5 Summarization Algorithm, median of all samples as baseline transformation).</s><s>The two sets of primary tumor samples (M0 and M1) were analyzed separately.</s><s>The corresponding expression data were archived under the GEO Accession No. GSE66272 and GSE66271.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA extraction and RT-qPCR analysis</head><p><s>Total RNA, including miRNAs was extracted from archived frozen ccRCC tissue histologically verified and renal cancer cell lines using the miRNeasy Mini Kit (QIAGEN, Hilden, Germany) according to the instructions provided by the manufacturer and previously described <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b17">18]</ref> (S1 Fig) <ref type="figure">.</ref></s><s>The adjacent normal tissue was selected at a distance of &gt;20 mm to the cancer tissue to avoid possible alterations of the non-neoplastic tissue through the tumor.</s><s>Total RNA quantity was determined on a NanoDrop 1000 Spectrometer (Thermo Fisher Scientific Inc., Nano-Drop products, Wilmington, DE, USA) by calculation of A260/230 and A260/280 ratios and the quality of the RNA was investigated using a Bioanalyzer 2100 (Agilent Technologies) with an RNA 6000 Nano Lab Chip.</s><s>Only samples with RNA integrity number values above 6 and ratios above 1.8 were included into the analysis.</s></p><p><s>For mRNA quantification, complementary DNA synthesis was performed using the Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Science, Mannheim, Germany).</s><s>The relative quantification of transcripts was done on the Light Cycler 480 (Roche Applied Science) using the QuantiTec SYBR Green PCR Kit as previously described <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>.</s><s>Briefly, 1 μg total RNA was reverse transcribed in a total volume of 20 μl.</s><s>For the PCR reactions, 1 μl of cDNA was amplified using 2.5 μM transcript-specific primers (TIB Molbiol, Berlin, Germany) in a final volume of 12.5 μl.</s><s>The reactions were performed at 95°C for 15 min, followed by 45 cycles with denaturation at 94°C for 15 s, variable primer annealing temperature for 30 s (S1 Table <ref type="table">)</ref> and elongation at 72°C for 30 s.</s><s>The samples were measured in triplicates and non-template control and interplate controls were included in each PCR run.</s></p><p><s>The TaqMan MicroRNA primer assays (Life Technologies GmbH, Applied Biosystems, Darmstadt, Germany) were used for determination of mature miRNA in accordance to the manufactures protocol and MIQE guidelines <ref type="bibr" target="#b21">[22]</ref> and previously described <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s>cDNA was synthesized with 6.67 ng of total RNA using TaqMan MicroRNA reverse transcription Kit (Life Technologies) and miRNA-specific stem-looped primers in a total volume of 10 μl.</s><s>PCR measurements were performed on the Light Cycler 480 Instrument (Roche) using 1 μl cDNA, 1x TaqMan Universal PCR Master Mix, No AmpErase UNG and miRNA-specific primers in a total volume of 10 μl in according to the manufacturer's recommendations.</s></p><p><s>PCR data were analyzed by GenEX software (MultiD Analyses AB, Göteborg, Sweden) or qBase PLUS software (Biogazelle NV, Gent, Belgium) using the correction of amplification efficiencies and the interplate variance.</s><s>The miRNA expression data were normalized to the reference gene combination of miR-28, miR-103, and miR-106a <ref type="bibr" target="#b17">[18]</ref>.</s><s>The mRNA expression data were normalized to the reference gene peptidylproline isomerase A (PPIA) <ref type="bibr" target="#b18">[19]</ref>.</s><s>The suitability of both normalization approaches using the mentioned reference genes was confirmed for this study (S2 Fig).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>Human kidney cancer cell lines 786-O and ACHN were used (American Type Culture Collection, Manassas, VA, USA).</s><s>786-O cells were maintained in RPMI 1640 (Life Technologies GmbH, Invitrogen, Darmstadt, Germany) and ACHN cells were cultured in Eagle's Minimum Essential Medium (Biochrom GmbH, Berlin, Germany).</s><s>The media were supplemented with 10% fetal calf serum (PAA Laboratories, Pasching, Austria) and 1% penicillin-streptomycin (PAA Laboratories) and both cell lines were grown in a humidified 5% CO 2 incubator at 37°C.</s></p><p><s>For transfection, 0.8x10 5 786-O cells or 2x10 5 ACHN cells per well were seeded into 6-well plates.</s><s>The next day, the cells were transfected with 30 nM mimic miR-146a, 30 nM mimic negative control 1 (NC1), and 50 nM inhibitor miR-146a (Life Technologies GmbH, Ambion, Darmstadt, Germany) using Lipofectamine2000 Reagent (Invitrogen).</s><s>After 48 h incubation, the supernatant was collected for CXCL8 ELISA assay, the cells were lysed in lysis buffer (0.5 mM Tris pH 6.8, 1% SDS, 1 mM EDTA, 1 mM PMSF, 100 μg/ml Trypsin Inhibitor, 10 μg/ml Aprotinin), and protein amount was determined for Western blot analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CXCL8 (IL8) ELISA assay</head><p><s>Media supernatant interleukin-8 (CXCL8, alias IL8) protein levels were measured using a solid phase sandwich Elisa (Human CXCL8 DuoSet ELISA kit; DY208-05, R&amp;D Systems Inc., Minneapolis, MN, USA).</s><s>A calibration curve was prepared with CXCL8 standards of 31.3, 62.5, 75, 125, 150, 250, 300, 500, and 1000 pg/ml.</s><s>Capture antibody (1:120), detection antibody (1:60), and streptavidin (1:40) were applied using an optimized protocol.</s><s>After incubation of the substrate solution for 10 min, the reaction was stopped and measured at 450 nm (reference 540 nm).</s><s>The experiment was performed three times in duplicates and CXCL8 production normalized to cell number.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>UHRF1 Western blot analysis</head><p><s>A total of 20 μg of protein per gel pocket were separated by SDS-PAGE (90 V for 15 min, 130 V for 1.5 h) before Western blotting (120 mA, overnight, 4°C).</s><s>The membrane was blocked in a 5% milk/PBS-T solution at RT for 2 h before application of the first antibodies rabbit-UHRF1 (1:200, #12387; Cell Signaling Technology, Danvers, MA, USA) and mouse-γ-tubulin (1:1000, sc-7396, Santa Cruz Biotechnology, Dallas, TX, USA) over night at 4°C.</s><s>The next day, secondary antibodies were applied (anti-rabbit/anti-mouse, 1:1000, Seramun Diagnostica GmbH, Heidesee, Germany) for 2 h at RT and developed using enhanced chemiluminescence method (Pierce Biotechnology, Rockford, IL, USA).</s><s>The experiment was repeated three times and densitometric analysis was performed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data analysis and statistics</head><p><s>miRNA-mRNA interactions were analyzed using the Ingenuity Pathway Analysis (IPA 1 ) (QIAGEN Redwood City, CA, www.qiagen.com/ingenuity)</s><s>as mentioned.</s><s>In detail, for the classification of the miRNA-mRNA interactions differentially expressed miRNAs were associated to experimentally validated and predicted mRNA targets from TarBase, miRecords, Target Scan, and the Ingenuity1 Knowledge Base.</s><s>The resulting miRNA-mRNA interactions pairs were mapped with the previously identified differentially expressed mRNAs.</s><s>The resulting interaction networks of differentially expressed miRNAs and mRNAs were visualized by IPA 1 .</s></p><p><s>Statistical analysis data were performed with GraphPad Prism 6.07.</s><s>(GraphPad Software, San Diego, CA, USA) and MedCalc 15.8 (MedCalc Software bvba, Ostend, Belgium).</s><s>The nonparametric Mann-Whitney U-test and the parametric Student's t-test with log-transformed data were used to analyze significant differences between the groups.</s><s>All tests were performed two-tailed and p&lt;0.05 values were considered statistically significant in all cases.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identification of miRNA target genes using IPA 1 's MicroRNA Target Filter</head><p><s>In order to identify new miRNA target gene interactions, which are involved in the process of tumor transition, we analyzed miRNA and mRNA expression profiles from malignant and non-malignant kidney tissue samples from patients with or without diagnosed metastasis.</s><s>Using IPA 1 's MicroRNA Target Filter analysis we found 54 differentially regulated miRNAs in the processed datasets of normal and ccRCC samples.</s><s>The 54 identified miRNAs, including associated miRNA families, target 13491 possible mRNAs.</s><s>These either experimentally observed or predicted miRNA-mRNA associations were sourced from TarBase, miRecords, Target Scan, and the Ingenuity 1 Knowledge Base.</s></p><p><s>In the next filtering step, we selected only experimentally observed miRNA-mRNA interactions based on inverse expression pairings in our datasets.</s><s>Subsequently, we focused only on observed relationships between miRNAs and mRNAs in the human species and relationships observed in cancer only.</s><s>Finally, we obtained a group of 32 miRNAs that associate with 348 mRNAs (S2 Table <ref type="table">)</ref>.</s><s>Among these significantly differentially expressed 32 miRNAs, IPA 1 's MicroRNA Target Filter identified three miRNAs (miR-146a-5p, miR-128a-3p, and miR-17-5p) that were upregulated in primary tumors from ccRCC-M0 patients and only downregulated in primary tumors from ccRCC-M1 patients (Fig <ref type="figure" target="#fig_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression of selected miRNAs in non-malignant, ccRCC-M0, and ccRCC-M1 samples</head><p><s>To confirm the results of the IPA 1 's MicroRNA Target Filter analysis, the three miRNAs miR-146a-5p, miR-128-3p, and miR-17-5p were revalidated by RT-qPCR in a second set of samples, including normal kidney and primary ccRCC samples from ccRCC-M0 and ccRCC-M1 patients.</s><s>miR-17-5p and miR-128-3p showed no significant differences in expression between the three sample groups, whereas miR-146a-5p was significantly higher expressed in the tested ccRCC-M0 and ccRCC-M1 tissues in comparison to the normal kidney (Table <ref type="table" target="#tab_0">1</ref>).</s><s>More importantly, miR-146a-5p is significantly lower expressed in metastatic primary ccRCC tumors (ccRCC-M1) in comparison to non-metastatic primary ccRCC tumors (ccRCC-M0) (Fig <ref type="figure" target="#fig_1">2</ref>).</s><s>It is of interest that miR-146a-5p shares the same seed sequence (GAGAACU) with the miR-146b-5p, and in IPA 1 , both miRNAs are associated in the same family mir-146.</s><s>However, miR-146b-5p was only differentially expressed between non-malignant tissue and ccRCC-M0 or ccRCC-M1 tissue samples but not between the two tumor tissues ccRCC-M0 and ccRCC-M1 (Table <ref type="table" target="#tab_0">1</ref>).</s><s>In consequence of these results, our further interest was only focused on the potential targets of miR-146a-5p.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Selection of mRNAs targeted by miR-146a-5p</head><p><s>Using IPA 1 ' s MicroRNA Target Filter analysis we obtained a set of 32 mRNA targets, which expression were inversely correlated to the miR-146a-5p expression (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>In ccRCC-M1, the expression of miR-146a-5p is significantly downregulated in comparison to ccRCC-M0.</s><s>Therefore, we were interested in mRNA targets out of the group of 32 which were highly upregulated in ccRCC-M1 (M1 vs normal) and lower expressed in ccRCC-M0 (M0 vs normal).</s><s>For further exploration, we selected five genes that have been previously experimentally demonstrated in other cancer setting in humans, CXCL8/IL8, UHRF1, BRCA1, MCM10, and CDKN3 (S3 Fig).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression of target mRNAs in non-malignant, ccRCC-M0 and ccRCC-M1 samples</head><p><s>The expression of the selected mRNA targets (CXCL8, UHRF1, BRCA1, MCM10, and CDKN3) were analyzed in pool samples from collectives of normal kidney, primary ccRCC-M0 and primary ccRCC-M1 tissues by RT-qPCR.</s><s>An upregulation of mRNA expression was detected in all five tested target mRNAs in ccRCC-M1 samples in comparison to ccRCC-M0 samples and normal kidney samples (Fig <ref type="figure" target="#fig_2">3)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experimental validation of mRNA-miR-146a-5p interaction in cancer cell lines</head><p><s>As proof of concept, we used the two different human kidney cancer cell lines, 786-O derived from primary ccRCC and ACHN derived from metastatic ccRCC.</s><s>The effect of miR-146a-5p on the expression level of the five selected mRNA targets in the two cell lines is summarized in Fig 4 <ref type="figure">.</ref></s><s>With the exception of BRCA1, we found significant expression changes of the other four mRNAs after miR-146a-5p treatment.</s></p><p><s>To confirm this regulatory effect also on the protein level, we exemplarily analyzed the protein expression of CXCL8/IL8 and UHRF1 in miRNA transfection experiments.</s><s>The transfection with miR-146a-5p significantly reduced the concentration of secreted CXCL8/IL8 protein from both cell lines whereas the inhibition of miR-146a-5p increased the amount of secreted CXCL8/IL8 measured by ELISA (Fig <ref type="figure">5</ref>).</s><s>The intracellular level of UHRF1 protein was detected by Western blotting.</s><s>Transfection with miR-146a-5p significantly reduced the amount of UHRF1 in both cell lines, however, a treatment with miR-146a-5p inhibitor showed no effect on UHRF1 expression (Fig <ref type="figure" target="#fig_4">6</ref>).</s><s>This missing effect was probably caused by the already low miR-146-5p levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Recent evidences indicated that miRNAs play an important role in the modulation of metastatic processes in solid tumors <ref type="bibr" target="#b23">[24]</ref>.</s><s>In case of RCC, a lot of miRNA expression profilings were performed in the last years to identify diagnostic and prognostic miRNA patterns or potential therapeutic targets <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref>.</s><s>A few studies also report on RCC metastasis related miRNA deregulation <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref>.</s><s>However, the knowledge about the transition from primary non-metastatic ccRCC into metastatic ccRCC is still limited.</s><s>In this respect, the integrated evaluation of expression data based on new bioinformatic algorithms can meet these challenges <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s></p><p><s>Here we analyzed miRNA and mRNA microarray expression profiles derived from primary ccRCC tumors from patients with (M1) or without (M0) diagnosed metastasis to get a better understanding of the tumor progression process.</s><s>We identified anti-correlated miRNA-mRNA interaction during the process of tumor transition.</s><s>By using our described IPA 1 filter settings, we obtained a network of miRNA-mRNA interaction pairs that showed an upregulation of specific miRNAs in primary tumors in ccRCC-M0 patients and a downregulation in primary tumors from ccRCC-M1 patients.</s><s>The corresponding target mRNAs were accordingly low expressed in primary tumors from M0 patients and upregulated in primary ccRCCs from M1 patients (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>In detail, the filter settings identified three miRNAs (miR-146a-5p, miR-128a-3p, and miR-17-5p), which showed a higher expression in tumors without metastasis than in tumors with metastasis.</s><s>The subsequent experimental validation of the microarray data analysis reduced the selection from these three miRNAs to only one miRNA (miR-146a-5p; Table <ref type="table" target="#tab_0">1</ref>) miR-146a-5p has already been described to be dysregulated in other types of tumors <ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref>, indicating an important role of this miRNA in carcinogenesis.</s><s>But it is necessary to point out that the regulation of microRNA is cancer-and target-specific.</s><s>A diverse behavior in different types of cancer has been described.</s><s>For example, in prostate and gastric cancers, miR-146a was upegulated and identified as tumor suppressor <ref type="bibr" target="#b39">[40,</ref><ref type="bibr" target="#b42">43]</ref> whereas it was downregulated and described as an oncogen in thyroid and cervical cancers <ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref>.</s><s>However, this miRNA as well as miR-146b-5p that shares the same seed sequence (GAGAACU) were not described as dysregulated miRNA in any of the ccRCC profiling studies mentioned above.</s><s>There were only two RCC studies that reported on the discrete upregulation of miR-146a-5p <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b47">48]</ref>, but no association to metastasis was found.</s><s>Our study demonstrated the same upregulation in the primary tumors (Table <ref type="table" target="#tab_0">1</ref>), but the data additionally complemented this analysis by showing that miR-146a-5p was downregulated when transition between primary tumors and metastasis aroused.</s><s>As the most profiling studies only use a criterion of at least two-fold decreased/increased expression as relevant result it can be assumed that the discretely altered expression of miR-146a-5p in RCC has been largely ignored until now.</s><s>On the other site, the usefulness of our approach is evident since the facility is improved to discover novel and complex cellular networks on the basis of anti-correlated expression of miRNA and mRNA using the Ingenuity pathway analysis microRNA Target Filter.</s><s>The network described in our study displays downregulation of miR-146a-5p in primary ccRCC of M1 patients to be associated with a significant upregulation of the target mRNAs BRCA1, MCM10, CDKN3, CXCL8, and UHRF1 (Fig <ref type="figure" target="#fig_2">3</ref>).</s><s>It has been taken into account, that all these mRNAs were also upregulated in ccRCC-M0 compared with normal kidney tissue (Fig <ref type="figure">4</ref>).</s><s>Nevertheless, we assume that ccRCC-M0 is the initial state to understand the mechanisms of metastatic transition.</s><s>By using our filter settings, we were able to determine the differential expression of both miRNAs and mRNAs between M0 and M1 primary tumors (Figs <ref type="figure" target="#fig_2">2 and 3</ref>).</s></p><p><s>Our further functional analysis was mainly focused on the two potential targets CXCL8 and UHRF1 of miR-146a-5p both on the mRNA and protein level.</s><s>The bioinformatic data obtained by the IPA 1 software was proven by transfection experiments in the two typical ccRCC cell lines 786-O and ACHN.</s><s>In the sense of gain-of-function experiments, increased miR-146a-5p CXCL8 is a proinflammatory chemokine involved in the neutrophils chemotaxis after infection.</s><s>Its role in cancer progression has been well documented <ref type="bibr" target="#b48">[49]</ref>.</s><s>Elevated expression of CXCL8 correlates with angiogenesis and VEGF expression in endothelial cells, an increase of proliferation and survival, an increase of migration of cancer cells, an induction of neutrophils on the tumor site, with tumorigenesis and metastasis in vivo models <ref type="bibr" target="#b49">[50]</ref>.</s><s>Especially the recent study from Huang and coworkers underlines the impact of CXCL8 on hepatocellular carcinoma metastasis formation in mice via increased FOXC1 expression <ref type="bibr" target="#b50">[51]</ref>.</s><s>An inflammatory microenvironment involving also CXCL8 seems to play an important role in hepatocellular carcinoma and its metastasis formation in general <ref type="bibr" target="#b51">[52]</ref>.</s></p><p><s>CXCL8 was also found to be linked to renal tumorigenesis.</s><s>Microarray profiling analysis revealed an association of CXCL8 gene expression and renal carcinoma <ref type="bibr" target="#b52">[53]</ref>.</s><s>Moreover, CXCL8 hypomethylation is associated with genomic instability in ccRCC vs normal tissue even though no correlation with the clinicopathological status of the patients was found <ref type="bibr" target="#b53">[54]</ref>.</s><s>Recently, another study could show that variant alleles (associated with high expression) in the CXCL8 gene are associated with poorer survival outcome in patients with RCC who received angiogenesis inhibitors <ref type="bibr" target="#b54">[55]</ref>.</s><s>Similarly, serum CXCL8 protein levels have been correlated with tumor burden in RCC patients <ref type="bibr" target="#b55">[56]</ref>.</s><s>Interestingly, an association of CXCL8 and miR-146a-5p was found in breast cancer cells and senescent human fibroblasts <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>.</s><s>Bhaumik et al. demonstrated that miR-146a/b-5p, when expressed in a highly metastatic human breast cell line, negatively regulated the NFκB activity.</s><s>This impaired NFκB activity resulted, among others, in a reduced secreted CXCL8 into the cell culture mediums <ref type="bibr" target="#b56">[57]</ref>.</s><s>The same group could further show the ectopic expressed miR-146a/b-5p indirectly suppressed IL6 and CXCL8 secretion in primary human fibroblasts <ref type="bibr" target="#b57">[58]</ref>, suggesting that miR-146a-5p and CXCL8 might share an inflammatory signaling pathway.</s><s>Our results may suggest that inflammation may be relevant also in ccRCC <ref type="bibr" target="#b55">[56]</ref>.</s></p><p><s>The other studied target of miR-146a-5p, UHRF1, plays a role in cell cycle progression and is required for tumor cell growth <ref type="bibr" target="#b58">[59,</ref><ref type="bibr" target="#b59">60]</ref>, migration and metastasis <ref type="bibr" target="#b60">[61]</ref>.</s><s>Knockdown of UHRF1 expression in cancer cells suppressed cell growth significantly, and the overexpression of UHRF1 promoted the proliferation of breast cancer cell lines by inducing apoptosis inhibition and angiogenesis <ref type="bibr" target="#b61">[62]</ref>.</s><s>UHRF1 acts as transcriptional repressor for the TP53 signaling pathway, by binding to specific gene promoters.</s><s>UHRF1 epigenetically regulates transcription by coordinating with histone deacetylase 1 <ref type="bibr" target="#b62">[63]</ref>, by binding to methylated histones (H3K9) and by promoting histone ubiquitination, DNA condensation, and suppression of tumor suppressor genes (CDKN2A, CDKN1A, RB1, MLH1, and PML).</s><s>UHRF1 was found to be overexpressed in many cancers, among them breast, colorectal, gastric cancer, and urinary bladder cancer (as reviewed in <ref type="bibr" target="#b63">[64]</ref>).</s><s>Data of upregulated UHRF1 expression in ccRCC was recently published after we had finished our experiments for this study <ref type="bibr" target="#b64">[65]</ref>.</s><s>The results both at mRNA and protein levels confirm our findings.</s></p><p><s>The upregulation of UHRF1 observed in the transition from primary tumors to metastasis in this study indicates that epigenetic modifications are probably intervening in this phenomenon and that miR-146a-5p is an important player in the regulation of the metastatic process in RCC.</s><s>Indeed, studies have shown that UHRF1 within a macromolecular protein complex promoted the ubiquitination and the degradation of DNA methyltransferase 1 and that it insured the epigenetic inheritance by assuring the maintenance of DNA methylation in African green monkey kidney fibroblast-like cell line <ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref>.</s><s>Interestingly, the miR-146a-UHRF1 regulation has been shown as a key event in the metastatic progression in gastric cancer <ref type="bibr" target="#b68">[69]</ref>.</s><s>This demonstrates that the relation between miR-146a-5p and UHRF1 may be a key axis in metastasis across carcinomas, including ccRCC as shown for the first time in our study.</s><s>These data also indicates that UHRF1 might be a potential therapeutic target in which the downregulation/ inhibition would help to decrease some of the biological processes involved in the metastatic progression as it was shown recently for esophageal squamous cell carcinoma <ref type="bibr" target="#b69">[70]</ref> or increased sensitivity of chemotherapeutic target as shown in breast cancer <ref type="bibr" target="#b70">[71]</ref>.</s></p><p><s>Associations between BRCA1, MCM1, and CDKN3 as the other three potential targets of miR-146a-5p and tumorigenesis were already reported for other cancers.</s><s>These targets should be only briefly characterized here, although we did not studied their relationship to ccRCC in such detail as in case of CXCL8 and UHRF1.</s></p><p><s>In contrast to our RCC example, triple-negative breast cancer is generally characterized by a downregulated BRCA1 expression and an upregulated miR-146a expression.</s><s>However, in this respect, converse experimental data were reported so far <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b71">72]</ref>.</s><s>Garcia et al. <ref type="bibr" target="#b37">[38]</ref> interpreted their results that miR-146a overexpression inactivates BRCA1 in triple-negative breast cancers whereas Fkih M'hamed et al. <ref type="bibr" target="#b71">[72]</ref> showed that BRCA1 expression in breast cancer lines MDA-MB-231 (triple-negative cell line) and MCF7 was not affected after transfection with miR-146a.</s><s>Here we could also not approve an impact of miR-146a-5p on BRCA1 expression.</s><s>Such an experimental failure to confirm a predicted target is not uncommon.</s><s>Since, there were no evidences of BRCA1 dysregulation in RCC reported in the literature, we could detect an upregulation of BRCA1 in RCC compared to normal tissue for the first time.</s></p><p><s>MCM10 as part of the family of minichromosome maintenance genes are involved in cell cycle progression by mediating the DNA replication initiation and elongation process.</s><s>MCM10 is essential in eukaryotic cells since the inactivation of MCM10 blocks the initiation of chromosome replication <ref type="bibr" target="#b72">[73,</ref><ref type="bibr" target="#b73">74]</ref>.</s><s>High expression of MCM10 was also found associated to cervical carcinogenesis <ref type="bibr" target="#b74">[75]</ref>.</s><s>The observed upregulation of MCM10 mRNA in ccRCC tumors from M1 patients as shown in our study is in line with a higher proliferative activity of the transformed primary tumor.</s></p><p><s>CDKN3 is a cyclin-dependent kinase inhibitor that regulates CDK2 kinase activation and reduce cell cycle activity <ref type="bibr" target="#b75">[76]</ref>.</s><s>On the other hand, CDKN3 is also promoting cell proliferation by reducing the sensitivity of CDKN1A and TP53 <ref type="bibr" target="#b76">[77]</ref>.</s><s>CDKN3 promotes tumorigenesis in ovarian, colorectal, and hepatocellular cancer <ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref><ref type="bibr" target="#b79">[80]</ref>.</s><s>Overexpression of CDKN3 enhances also cell proliferation in renal cancer cells <ref type="bibr" target="#b80">[81]</ref>.</s><s>Therefore, the observed upregulation of CDKN3 in our ccRCC tumors from M1-patients correspond with these previous findings.</s></p><p><s>In summary, by comparing miRNA and mRNA microarray expression profiles and using for this purpose the IPA 1 's microRNA Target Filter software from QIAGEN, we identified a network of anti-correlated miRNA-mRNA that is involved in transition from primary RCC tumors to metastasis.</s><s>We found miR-146a-5p to be downregulated and MCM10, CDKN3, CXCL8, and UHRF1 to be upregulated in this process.</s><s>This approach of systems biology using an integrated evaluation of expression data from different molecular analytes has allowed us to preselect possible diagnostic, prognostic, and therapeutic targets through analyses of interconnected networks and datasets.</s><s>The advantage to use such an integrated approach is helpful in planning studies, discovering novel interactions between molecular components, and dealing sparingly and efficiently with experimental resources.</s><s>We believe that the deeper insight into the processes taking place in the transition between the non-metastatic and metastatic primary tumor does not only allows the detection of new targets but also new biomarkers.</s><s>In that case, a corresponding marker or model of combined marker in tumor tissue samples could be a helpful tool for discrimination between the mentioned different risk probabilities without the use of normal tissue.</s><s>We demonstrated this concept in a recently published study on the different expression of piwi-RNAs in primary RCC samples <ref type="bibr" target="#b81">[82]</ref>.</s><s>Further studies are warranted for understanding the role of the other 27 genes.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Interaction Network between 3 differentially expressed miRNAs (downregulated M1 vs M0, green) and differentially expressed mRNAs (upregulated M1 vs M0, red) from ccRCC patients.</s><s>doi:10.1371/journal.pone.0148746.g001</s></p></div></figDesc><graphic coords="7,36.00,78.01,535.19,442.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Expression of miR-146a-5p in ccRCC tissue samples.</s><s>RT-qPCR analysis of the expression of miR-146a-5p in ccRCC tissue samples was performed.</s><s>The data are represented in a scatter dot plots with means for normal, non-malignant renal tissue samples (N; n = 10), primary tumor samples without diagnosed metastasis (ccRCC-M0; n = 10), and primary tumor samples with diagnosed metastasis (ccRCC-M1; n = 10).</s><s>Normalization was assessed with the reference miRNA combination miR-28, miR-103, and miR-106a [18], (S2 Fig).</s><s>Statistical differences were calculated using the Mann-Whitney U test between the groups.</s><s>doi:10.1371/journal.pone.0148746.g002</s></p></div></figDesc><graphic coords="9,36.00,78.01,428.61,491.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Expression of putative mRNAs targeted of miR-146a-5p.</s><s>The relative mRNA expression levels of the potential miR-146a-5p targets BRCA1, MCM10, CDKN3, CXCL8/IL8, and UHRF1 were measured in duplicates in a pool of normal renal tissue and tissue samples from primary ccRCC-M0 and ccRCC-M1 patients by RT-qPCR.</s><s>Data were normalized with PPIA reference gene [19], (S2 Fig).</s><s>BRCA1, CDKN3, MCM10, CXCL8/IL8, and UHRF1 are lower in tissue samples of ccRCC without metastasis compared to ccRCC with metastasis.</s><s>doi:10.1371/journal.pone.0148746.g003</s></p></div></figDesc><graphic coords="10,36.00,78.01,478.56,292.03" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 4 .Fig 5 .</head><label>45</label><figDesc><div><p><s>Fig 4. Effect of miR-146a-5p on putative mRNA target levels in 786-O and ACHN cells.</s><s>Application of miR-146a-5p mimic and miR-146a-5p inhibitor effects mRNA target expression in cell lines.</s><s>Data were normalized with PPIA reference gene [19].</s><s>NC1 = negative control.</s><s>doi:10.1371/journal.pone.0148746.g004</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 6 .</head><label>6</label><figDesc><div><p><s>Fig 6.</s><s>Effect of miR-146a-5p on UHRF1 protein levels in 786-O and ACHN cells.</s><s>(A) Western blots and (B, C) their densitometric analyses showed a reduced UHRF1 protein expression in 786-O and ACHN cells after application of the miR-146a-5p mimic, whereas the miR-146a-5p inhibitor had no effect on UHRF1 expression levels in both cell lines.</s><s>NC1 = negative control.</s><s>doi:10.1371/journal.pone.0148746.g006</s></p></div></figDesc><graphic coords="13,36.00,78.01,517.89,422.87" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Expression of selected miRNAs in non-malignant, ccRCC-M0 and ccRCC-M1 samples.Statistical differences were calculated using the Mann-Whitney U test between tissue groups (Normal, ccRCC-M0, and ccRCC-M1) for each miRNA.</s></p></div></figDesc><table><row><cell>miRNA</cell><cell>ccRCC-M0 to Normal a</cell><cell></cell><cell>ccRCC-M1 to ccRCC-M0 a</cell><cell></cell><cell>ccRCC-M1 to Normal a</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Folds (mean ± SD)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>p-value b</cell><cell></cell><cell>p-value b</cell><cell cols="2">p-value b</cell></row><row><cell>miR-17-5p</cell><cell>2.56 ± 0.70 to 2.13 ± 0.35</cell><cell>0.241</cell><cell>2.79 ± 0.97 to 2.56 ± 0.70</cell><cell>0.762</cell><cell>2.79 ± 0.97 to 2.13 ± 0.35</cell><cell>0.104</cell></row><row><cell>miR-128a-3p</cell><cell>0.38 ± 0.27 to 0.27 ± 0.06</cell><cell>0.937</cell><cell>0.34 ± 0.16 to 0.38 ± 0.27</cell><cell>0.762</cell><cell>0.34 ± 0.16 to 0.27 ± 0.06</cell><cell>0.649</cell></row><row><cell>miR-146a-5p</cell><cell>2.05 ± 0.79 to 0.82 ± 0.2</cell><cell>&lt;0.001</cell><cell>1.2 ± 0.47 to 2.05 ± 0.79</cell><cell>0.007</cell><cell>1.2 ± 0.47 to 0.82 ± 0.2</cell><cell>0.028</cell></row><row><cell>miR-146b-5p</cell><cell>1.96 ± 1.13 to 0.81 ± 0.35</cell><cell>0.005</cell><cell>2.11 ± 1.52 to 1.96 ± 1.13</cell><cell>1.000</cell><cell>2.11 ± 1.52 to 0.81 ± 0.35</cell><cell>0.019</cell></row><row><cell cols="7">a Quantitative RT-PCR analysis of miR-17-5p, miR-128a, and miR-146a-5p was performed in different tissue samples: normal, non-malignant renal tissue</cell></row><row><cell cols="7">(n = 10, Normal), primary ccRCC samples without diagnosed metastasis (n = 10, ccRCC-M0), and primary ccRCC samples with diagnosed metastasis</cell></row><row><cell cols="6">(n = 10, ccRCC-M1). Normalization was assessed with the reference miRNA combination miR-28, miR-103, and miR-106a [18], (S2 Fig).</cell><cell></cell></row><row><cell cols="2">doi:10.1371/journal.pone.0148746.t001</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>b</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0148746 February 9, 2016</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We would like to thank Sabine Becker, Silke Rabenhorst, and Dr. Monika Jung for their valuable assistance in performing this study.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cancer statistics</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21254</idno>
		<idno type="PMID">25559415</idno>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="5" to="29" />
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">SEER data submission, posted to the SEER web site</title>
		<author>
			<persName><forename type="first">N</forename><surname>Howlader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Noone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Krapcho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garshell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Altekruse</surname></persName>
		</author>
		<ptr target="http://seer.cancer.gov/csr/1975_2011/.Accessed" />
	</analytic>
	<monogr>
		<title level="j">Cancer Statistics Review</title>
		<imprint>
			<date type="published" when="1975">1975-2011. November 2013. April 2014. 2015 November 8</date>
		</imprint>
		<respStmt>
			<orgName>National Cancer Institute</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Guidelines on Renal Cell Carcinoma</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ljungberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bensalah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bex</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Canfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dabestani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Giles</surname></persName>
		</author>
		<ptr target="http://www.uroweb.org/guidelines/online-guidelines" />
		<imprint>
			<date type="published" when="2015-11-08">2015 update. 2015 November 8</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Van Poppel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Da</forename><surname>Pozzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Albrecht</forename><forename type="middle">W</forename><surname>Matveev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Borkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="PMID">17140723</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1606" to="1615" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Current status of targeted therapy in metastatic renal cell carcinoma</title>
		<author>
			<persName><forename type="first">De</forename><surname>Mulder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Patard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Szczylik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Urol Suppl</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="665" to="671" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Prognostic factors and staging systems for renal cell carcinoma</title>
		<author>
			<persName><forename type="first">V</forename><surname>Ficarra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Galfano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Verhoest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cavalleri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Martignoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Artibani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Urol Suppl</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="623" to="629" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Yousef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrurol.2010.45</idno>
		<idno type="PMID">20368743</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Urol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="286" to="297" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Comprehensive molecular characterization of clear cell renal cell carcinoma</title>
		<idno type="DOI">10.1038/nature12222</idno>
		<idno type="PMID">23792563</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">499</biblScope>
			<biblScope unit="page" from="43" to="49" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>The Cancer Genome Atlas Research Network</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Butz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Szabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nofech-Mozes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rotondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kovacs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mirham</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2014.225854</idno>
		<idno type="PMID">25139457</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1314" to="1326" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Integrated molecular analysis of clear-cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshizato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shiraishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maekawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kamura</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2699</idno>
		<idno type="PMID">23797736</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="860" to="867" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0022570</idno>
		<idno type="PMID">21799901</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e22570</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Network-constrained forest for regularized classification of omics data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Andel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Krejcik</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ymeth.2015.04.006</idno>
		<idno type="PMID">25872185</idno>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="88" to="97" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Disch</surname></persName>
		</author>
		<idno type="DOI">10.7150/ijbs.5106</idno>
		<idno type="PMID">23139634</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Biol Sci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1363" to="1374" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kempkensteffen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weikert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Schaser</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cca.2012.11.010</idno>
		<idno type="PMID">23178446</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chim Acta</title>
		<imprint>
			<biblScope unit="volume">416</biblScope>
			<biblScope unit="page" from="5" to="10" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">MicroRNAs as regulators of signal transduction in urological tumors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Yousef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2010.157727</idno>
		<idno type="PMID">21632885</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="954" to="968" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Prognostic significance of morphologic parameters in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Fuhrman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Lasky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Limas</surname></persName>
		</author>
		<idno type="PMID">7180965</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="655" to="663" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m" type="main">TNM classification of malignant tumours</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Sobin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wittekind</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2002">2002</date>
			<publisher>Wiley-Liss</publisher>
			<biblScope unit="page" from="193" to="195" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ab.2011.06.009</idno>
		<idno type="PMID">21741950</idno>
	</analytic>
	<monogr>
		<title level="j">Anal Biochem</title>
		<imprint>
			<biblScope unit="volume">417</biblScope>
			<biblScope unit="page" from="233" to="241" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ramankulov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roigas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johannsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ringsdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kristiansen</surname></persName>
		</author>
		<idno type="PMID">17559644</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Mol Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">47</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tolle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Fritzsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Haendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kristiansen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2008.04.001</idno>
		<idno type="PMID">18450365</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="669" to="678" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rabien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Burkhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fritzsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ringsdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schicktanz</surname></persName>
		</author>
		<idno type="PMID">16806661</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1259" to="1266" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Bustin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Benes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Garson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hellemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huggett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kubista</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2008.112797</idno>
		<idno type="PMID">19246619</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="611" to="622" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Robust microRNA stability in degraded RNA preparations from human tissue and cell samples</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kempkensteffen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Erbersdobler</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2009.141580</idno>
		<idno type="PMID">20378769</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="998" to="1006" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Regulation of microRNAs in cancer metastasis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bouyssou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Manier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Issa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Roccaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Ghobrial</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbcan.2014.02.002</idno>
		<idno type="PMID">24569228</idno>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1845</biblScope>
			<biblScope unit="page" from="255" to="265" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Pal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Jin</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0035661</idno>
		<idno type="PMID">22623952</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e35661</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Identification of a microRNA panel for clear-cell kidney cancer</title>
		<author>
			<persName><forename type="first">D</forename><surname>Juan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Alexe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Antes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Madabhushi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delisi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.urology.2009.10.033</idno>
		<idno type="PMID">20035975</idno>
	</analytic>
	<monogr>
		<title level="j">Urology</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="835" to="841" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Mollenkopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Grimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Albrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waller</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1582-4934.2009.00705.x</idno>
		<idno type="PMID">19228262</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Mol Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="3918" to="3928" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">MicroRNA profiling of human kidney cancer subtypes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Petillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Kort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Furge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Teh</surname></persName>
		</author>
		<idno type="PMID">19513557</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Oncol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="109" to="114" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep10272</idno>
		<idno>PMID:</idno>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">10272</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Integrated profiling of microRNAs and mRNAs: micro-RNAs located on Xq27.3 associate with clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0015224</idno>
		<idno type="PMID">21253009</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e15224</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Grigull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Youssef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Girgis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Diamandis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.juro.2011.04.110</idno>
		<idno type="PMID">21784468</idno>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="1077" to="1083" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Heinzelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Henning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sanjmyatav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Posorski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wunderlich</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00345-010-0633-4</idno>
		<idno type="PMID">21229250</idno>
	</analytic>
	<monogr>
		<title level="j">World J Urol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="367" to="373" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases</title>
		<author>
			<persName><forename type="first">J</forename><surname>Heinzelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Unrein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Wickmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baumgart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stapf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Szendroi</surname></persName>
		</author>
		<idno type="DOI">10.1245/s10434-013-3361-3</idno>
		<idno type="PMID">24242678</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Surg Oncol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1046" to="1054" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Khella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Faragalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gabril</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boazak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dorian</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-011-0255-5</idno>
		<idno type="PMID">22086373</idno>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="131" to="140" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Fei</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2015.3799</idno>
		<idno type="PMID">25682771</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1571" to="1578" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients</title>
		<author>
			<persName><forename type="first">O</forename><surname>Slaby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Redova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Poprach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nekvindova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Iliev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Radova</surname></persName>
		</author>
		<idno type="DOI">10.1002/gcc.21957</idno>
		<idno type="PMID">22492545</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="707" to="716" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Khella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Grigull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Adzovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Youssef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Honey</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2011.401</idno>
		<idno type="PMID">22033272</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1741" to="1749" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Buisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bertrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rimokh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rouleau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Lopez</surname></persName>
		</author>
		<idno type="DOI">10.1002/emmm.201100136</idno>
		<idno type="PMID">21472990</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO Mol Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="279" to="290" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.3892/ijo.2014.2415</idno>
		<idno type="PMID">24805774</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Oncol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="197" to="208" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jiang</surname></persName>
		</author>
		<idno type="DOI">10.1002/pros.22878</idno>
		<idno type="PMID">25214035</idno>
	</analytic>
	<monogr>
		<title level="j">Prostate</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="1613" to="1621" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">25755772</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Clin Exp Pathol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="765" to="771" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor</title>
		<author>
			<persName><forename type="first">U</forename><surname>Warnecke-Eberz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Chon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Holscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Drebber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bollschweiler</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-015-3112-0</idno>
		<idno type="PMID">25631748</idno>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="4643" to="4653" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Clinical significance of miR-146a in gastric cancer cases</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kogo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mimori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Komune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mori</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-10-2866</idno>
		<idno type="PMID">21632853</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="4277" to="4284" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Nuclear factor-κB contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a</title>
		<author>
			<persName><forename type="first">F</forename><surname>Pacifico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Crescenzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mellone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iannetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Porrino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Liguoro</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2009-1128</idno>
		<idno type="PMID">20061417</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="1421" to="1430" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.3233/CBM-140431</idno>
		<idno type="PMID">25524940</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Biomarkers</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="33" to="40" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Aberrant expression of oncogenic and tumorsuppressive microRNAs in cervical cancer is required for cancer cell growth</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meyers</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0002557</idno>
		<idno type="PMID">18596939</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e2557</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">MicroRNA expression signatures of stage, grade, and progression in clear cell RCC</title>
		<author>
			<persName><forename type="first">B</forename><surname>Gowrishankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ibragimova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Slifker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Devarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Al-Saleem</surname></persName>
		</author>
		<idno type="DOI">10.4161/cbt.27314</idno>
		<idno type="PMID">24351440</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Biol Ther</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="329" to="341" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Bang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Son</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Mun</surname></persName>
		</author>
		<idno type="DOI">10.3892/mmr_00000251</idno>
		<idno type="PMID">21472233</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Med Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="275" to="279" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">The chemokine CXCL8 in carcinogenesis and drug response</title>
		<author>
			<persName><forename type="first">D</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Manne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Samuel</surname></persName>
		</author>
		<idno type="DOI">10.1155/2013/859154</idno>
		<idno type="PMID">24224100</idno>
	</analytic>
	<monogr>
		<title level="j">ISRN Oncol</title>
		<imprint>
			<biblScope unit="page">859154</biblScope>
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The interleukin-8 pathway in cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Waugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wilson</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-07-4843</idno>
		<idno type="PMID">18980965</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="6735" to="6741" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Interleukin-8 induces expression of FOXC1 to promote transactivation of CXCR1 and CCL2 in hepatocellular carcinoma cell lines and formation of metastases in mice</title>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fan</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2015.05.058</idno>
		<idno type="PMID">26065367</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="1053" to="1067" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment</title>
		<author>
			<persName><forename type="first">P</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1111/jcmm.12153</idno>
		<idno type="PMID">24268047</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Mol Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="218" to="230" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways</title>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Che</forename><forename type="middle">J</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
		<idno type="DOI">10.1159/000355726</idno>
		<idno type="PMID">24247930</idno>
	</analytic>
	<monogr>
		<title level="j">Kidney Blood Press Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="506" to="513" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Chang</surname></persName>
		</author>
		<idno type="PMID">23255890</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="39" to="42" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">IL8 polymorphisms and overall survival in pazopanib-or sunitinib-treated patients with renal cell carcinoma</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garcia-Donas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Choueiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Sternberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1190" to="1198" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Sanmamed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Carranza-Rua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alfaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Onate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Martin-Algarra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perez</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-13-3203</idno>
		<idno type="PMID">25224278</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="5697" to="5707" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bhaumik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schokrpur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Patil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Campisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Benz</surname></persName>
		</author>
		<idno type="DOI">10.1038/onc.2008.171</idno>
		<idno type="PMID">18504431</idno>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="5643" to="5647" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bhaumik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schokrpur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Patil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Orjalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rodier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aging (Albany NY)</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="402" to="411" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Arima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hirota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bronner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mousli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Niwa</surname></persName>
		</author>
		<idno type="PMID">15009091</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Cells</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="131" to="142" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Markovtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pearsall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Warner</surname></persName>
		</author>
		<idno type="PMID">16195352</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Biol Cell</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="5621" to="5629" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11010-014-2279-9</idno>
		<idno type="PMID">25416862</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">400</biblScope>
			<biblScope unit="page" from="223" to="232" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Exogenous expression of UHRF1 promotes proliferation and metastasis of breast cancer cells</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Nie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Fan</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2012.1792</idno>
		<idno type="PMID">22552622</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="375" to="383" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Unoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nishidate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakamura</surname></persName>
		</author>
		<idno type="PMID">15361834</idno>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="7601" to="7610" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bronner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Krifa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mousli</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2013.10.002</idno>
		<idno type="PMID">24134914</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1643" to="1649" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2015.06.104</idno>
		<idno type="PMID">26102039</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">464</biblScope>
			<biblScope unit="page" from="147" to="153" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">UHRF1 plays a role in maintaining DNA methylation in mammalian cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bostick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Esteve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pradhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Jacobsen</surname></persName>
		</author>
		<idno type="PMID">17673620</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">317</biblScope>
			<biblScope unit="page" from="1760" to="1764" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Guda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.1126/scisignal.2001462</idno>
		<idno type="PMID">21045206</idno>
	</analytic>
	<monogr>
		<title level="j">Sci Signal</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">80</biblScope>
			<date type="published" when="2010">2010. 2001462</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sharif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Muto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Takebayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Suetake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iwamatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Endo</surname></persName>
		</author>
		<idno type="PMID">17994007</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">450</biblScope>
			<biblScope unit="page" from="908" to="912" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1096/fj.13-233387</idno>
		<idno type="PMID">23982143</idno>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="4929" to="4939" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jing</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11033-013-2559-6</idno>
		<idno type="PMID">23943380</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Biol Rep</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="5225" to="5235" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo</title>
		<author>
			<persName><forename type="first">L</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shanqu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ping</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ke</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00280-011-1801-y</idno>
		<idno type="PMID">22205202</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Chemother Pharmacol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1079" to="1087" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fkih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>'hamed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Privat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ponelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Penault-Llorca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kenani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Bignon</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13402-015-0239-3</idno>
	</analytic>
	<monogr>
		<title level="m">Epub ahead of print</title>
				<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Mcm10 associates with the loaded DNA helicase at replication origins and defines a novel step in its activation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Van Deursen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sengupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sanchez-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Labib</surname></persName>
		</author>
		<idno type="DOI">10.1038/emboj.2012.69</idno>
		<idno type="PMID">22433841</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2195" to="2206" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Inoue</surname></persName>
		</author>
		<idno type="PMID">15195143</idno>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="6250" to="6260" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Govardhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0069607</idno>
		<idno type="PMID">23874974</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e69607</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Chao</surname></persName>
		</author>
		<idno type="PMID">12745075</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="311" to="314" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction</title>
		<author>
			<persName><forename type="first">K</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kitabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Taya</surname></persName>
		</author>
		<idno type="PMID">17056014</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="216" to="222" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer</title>
		<author>
			<persName><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Guo</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2014.3045</idno>
		<idno type="PMID">24573179</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1825" to="1831" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Xing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ding</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2012.02.107</idno>
		<idno type="PMID">22390936</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">420</biblScope>
			<biblScope unit="page" from="29" to="35" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Mechanistic studies of cyclin-dependent kinase inhibitor 3 (CDKN3) in colorectal cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Sun</surname></persName>
		</author>
		<idno type="PMID">25735390</idno>
	</analytic>
	<monogr>
		<title level="j">Asian Pac J Cancer Prev</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="965" to="970" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Pang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Yeh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.urolonc.2010.09.010</idno>
		<idno type="PMID">21396835</idno>
	</analytic>
	<monogr>
		<title level="j">Urol Oncol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="871" to="878" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas</title>
		<author>
			<persName><forename type="first">J</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ralla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Trujillo-Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schwabe</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13046-015-0180-3</idno>
		<idno type="PMID">26071182</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page">61</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
